Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 21, 2015; 21(7): 2214-2219
Published online Feb 21, 2015. doi: 10.3748/wjg.v21.i7.2214
Published online Feb 21, 2015. doi: 10.3748/wjg.v21.i7.2214
Before treatment | After treatment | |||||
Patient 1 | Patient 2A | Patient 2B | Patient 1 | Patient 2A | Patient 2B | |
Albumin (g/L) | 35 | 28 | 33 | 38 | 24 | 37 |
ASAT (U/L) | 5463 | 1310 | 2306 | 13 | 68 | 74 |
ALAT (U/L) | 5144 | 1832 | 3678 | 14 | 9 | 83 |
GGT (U/L) | 77 | 94 | 111 | 24 | 32 | 137 |
AP (U/L) | 157 | 144 | 99 | 56 | 204 | 122 |
pH | 7.42 | - | 7.43 | 7.44 | 7.37 | 7.42 |
Lactate (mmol/L) | 2.5 | - | 2.8 | 0.5 | 2.1 | 2.2 |
Bilirubin (mg/dL) | 11.4 | 26.1 | 29.8 | 0.7 | 9.7 | 1.2 |
International normalized ratio | 2.18 | 1.81 | 1.92 | 1.07 | 1.27 | 1.27 |
- Citation: Bockmann JH, Dandri M, Lüth S, Pannicke N, Lohse AW. Combined glucocorticoid and antiviral therapy of hepatitis B virus-related liver failure. World J Gastroenterol 2015; 21(7): 2214-2219
- URL: https://www.wjgnet.com/1007-9327/full/v21/i7/2214.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i7.2214